| Financial Year |
March 31 2023 |
| Monetary Funds |
1,823,596,729.34 |
| Held-for-trading Financial Assets |
743,811.86 |
| Notes Receivable |
312,211,469.96 |
| Accounts Receivable |
1,851,303,561.84 |
| Advances to Suppliers |
467,163,458.82 |
| Other Receivables |
72,298,634.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,108,475,959.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,755,867.98 |
| Total Current Assets |
9,295,377,416.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
174,769,658.55 |
| Investment Properties |
46,165,244.91 |
| Fixed Assetes |
374,199,814.46 |
| Under-construction Projects |
562,866,356.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
190,471,388.96 |
| R&D expenses |
-- |
| Goodwill |
688,245,627.45 |
| Long-Term Deferred and Prepaid Expenses |
19,808,777.37 |
| Deferred Income Tax Assets |
45,098,468.13 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,162,897,776.92 |
| Total Assets |
11,458,275,193.56 |
| Short-Term Loans |
324,683,370.19 |
| Trading Financial liabilities |
5,754,844.66 |
| Notes Payable |
1,582,450,794.85 |
| Accounts Payable |
2,419,496,905.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
58,320,448.76 |
| Taxes Payable |
59,717,567.23 |
| Interest Payable |
1,074,786.67 |
| Dividend Payable |
928,548.67 |
| Other payables |
114,683,685.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
497,648,451.31 |
| Sub-Total of Current Liabilities |
7,576,558,001.23 |
| Long-term Loans |
405,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,580,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,441,685.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
449,701,027.57 |
| Total Liabilities |
8,026,259,028.80 |
| Paid-In Capital(Or Share Stock) |
622,874,778.00 |
| Capital Surplus |
2,055,791,140.97 |
| Surplus Reserve |
183,994,028.58 |
| LESS:Treasury Stock |
24,765,406.07 |
| Undistributed Profits |
530,269,685.13 |
| Minority Stockholder's Interest |
74,821,943.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,357,194,221.14 |
| Owner's Equity（Stockholder's Equity） |
3,432,016,164.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,458,275,193.56 |
